Junning Ma | Clinical Nano Science | Editorial Board Member

Published on by Invention Awards

Editorial Board Member

Junning Ma
Zhejiang University

Junning Ma
Affiliation Zhejiang University
Country China
Citations 314
Works 4
Subject Area Clinical Nano Science
Event International Invention Awards
ORCID 0000-0003-3499-8246

Junning Ma is identified in the supplied profile as a researcher affiliated with Zhejiang University, China, with a stated research area of Clinical Nano Science. The profile reports four research works and 314 citations, although these bibliometric figures require independent verification against the relevant database. The researcher’s ORCID identifier provides a persistent reference for checking scholarly identity and associated research outputs. This article summarizes the available profile information and its relevance to academic research and the International Invention Awards, without attributing unverified publications or discoveries to the researcher. [1]

Abstract

This article presents a researcher profile for Junning Ma, identified in the supplied information as being affiliated with Zhejiang University, China, and working in the area of Clinical Nano Science. The available profile reports four research works and 314 citations, figures that require verification against authoritative bibliographic records. An ORCID identifier is included to facilitate researcher identification and discovery of associated scholarly outputs. The article reviews the research profile, potential contributions, publication information, scholarly impact, and relevance to the International Invention Awards. A comprehensive evaluation requires verified publications, documented research achievements, and evidence demonstrating originality, scientific significance, and practical impact.

Keywords

Junning Ma; Zhejiang University; Clinical Nano Science; nanoscience; nanotechnology; clinical research; scholarly publications; research impact; ORCID; academic recognition; International Invention Awards.

Introduction

Clinical nanoscience combines nanoscale materials and technologies with biomedical research to investigate potential applications in diagnosis, imaging, treatment, and healthcare. Its interdisciplinary nature requires evaluation of experimental evidence, methodological rigor, and the relevance of findings to clinical or scientific challenges. The supplied information identifies Junning Ma with Zhejiang University and Clinical Nano Science. Establishing a reliable research biography requires confirmation of the researcher’s identity, institutional affiliation, publications, and specific contributions using authoritative sources. Persistent researcher identifiers and bibliographic databases are useful tools for supporting this verification process. [1]

Research Profile

The supplied profile identifies Junning Ma as affiliated with Zhejiang University, China, and reports four research works and 314 citations. These figures provide preliminary bibliometric information but do not independently establish publication quality, authorship accuracy, or the significance of individual contributions. The supplied ORCID identifier can be used to investigate the researcher’s registered scholarly activities. Verification should include matching author names, institutional affiliations, publication metadata, and persistent identifiers to ensure that records are correctly attributed and that the profile remains accurate. [1] [2]

Research Contributions

Research contributions in clinical nanoscience may include developing nanomaterials, improving biomedical measurement techniques, investigating nanoscale interactions, or exploring technologies for clinical applications. The value of a contribution depends on the originality of the research question, the reliability of its methods, and the reproducibility and significance of its results. The supplied information does not identify specific publications, inventions, or experimental findings attributable to Junning Ma. Individual contributions should therefore be documented using original research papers, verified project records, and other appropriate supporting evidence before definitive claims are made.

Publications

The profile information reports four research works, but individual publication titles, journals, publication dates, DOI identifiers, and author positions have not been supplied. These details should be obtained from verified scholarly records rather than generated from incomplete information. Scopus and other bibliographic databases can support the identification of relevant publications and citation records. Each publication should be checked for correct authorship, institutional affiliation, and DOI resolution before inclusion in a formal academic biography or award evaluation. [2]

Research Impact

The reported citation count of 314 may provide an initial indication of scholarly visibility, subject to verification of the database and researcher identity. Citation metrics vary according to database coverage, publication age, disciplinary conventions, and collaborative practices. A balanced impact assessment should also consider the quality of the research, independent use of findings, reproducibility, and demonstrable scientific or clinical outcomes. The h-index is not available in the supplied information and should not be inferred from the reported citation count or number of research works. [2]

Award Suitability

The International Invention Awards is the recognition event specified for this profile. Assessment for an award should consider the applicable eligibility requirements, originality, documented individual contributions, scientific or technical merit, and evidence of impact. The supplied research profile can provide preliminary background information but is not sufficient on its own to establish eligibility or selection. A comprehensive assessment should use a verified curriculum vitae, relevant publications, supporting evidence of research or inventions, and the official award criteria published by the organizers. [3]

Conclusion

The supplied information presents Junning Ma as a researcher affiliated with Zhejiang University, China, in the subject area of Clinical Nano Science. Four research works and 314 citations are reported, and an ORCID identifier is provided for further verification. The Scopus author ID, h-index, individual publication records, and specific research achievements remain unverified or unavailable. Confirmation against authoritative academic records is necessary before treating the profile as a complete, independently verified biography or using it as the basis for formal recognition.

References

  1. ORCID. (n.d.). ORCID: Connecting Research and Researchers. ORCID
    https://orcid.org/0000-0003-3499-8246
  2. Journal article. (2019. ). Targeted Drug Delivery to Stroke via Chemotactic Recruitment of Nanoparticles Coated with Membrane of Engineered Neural Stem Cells.
    https://doi.org/10.1002/smll.201902011
  3. International Invention Awards. (2026.). Official website.
    https://inventionawards.org/

Assoc. Prof. Dr. Yousef Bin Jardan | Pharmaceutical Sciences | Best Researcher Award

Published on by Invention Awards

Assoc. Prof. Dr. Yousef Bin Jardan | Pharmaceutical Sciences | Best Researcher Award

King Saud University, Saudi Arabia.

Yousef Abdullah M. Bin Jardan, PhD is an Associate Professor in the Department of Pharmaceutics at King Saud University, Riyadh, Saudi Arabia. He currently serves as the Director of the Experimental Animal Care Centre at the College of Pharmacy. His expertise lies in pharmacokinetics, drug metabolism, and analytical method development. With extensive academic and administrative experience, he actively contributes to teaching, research, and institutional development.

Profile

Scopus
Orcid

🎓 Education

Assoc. Prof. Dr. Yousef Bin Jardan holds a Ph.D. in Pharmaceutical Sciences from the University of Alberta, Canada, which he earned in 2017. He previously obtained his B.Sc. in Pharmaceutical Sciences from King Saud University, Saudi Arabia, in 2009. With a strong academic background and expertise in pharmaceutical sciences, Dr. Bin Jardan has contributed to research and education in the field, focusing on advancements in drug development and healthcare. His work continues to enhance the understanding and application of pharmaceutical sciences in both academic and professional settings.

🎓 Academic Positions

Assoc. Prof. Dr. Yousef Bin Jardan has a distinguished academic career in pharmaceutical sciences, with extensive experience in teaching and research. Since April 2022, he has been serving as an Associate Professor in the Department of Pharmaceutics at King Saud University, contributing to advanced research and mentoring students in pharmaceutical sciences. Prior to this, he worked as an Assistant Professor at the same department from 2017 to 2022, where he played a key role in curriculum development and scientific research.

Before joining King Saud University as a faculty member, Dr. Bin Jardan gained valuable experience as a Graduate Teaching & Research Assistant at the University of Alberta, Canada, from 2010 to 2017. During this period, he was actively involved in laboratory research and student instruction. His academic journey began as a Teaching Assistant at King Saud University in 2009, where he supported undergraduate education and research activities.

👨‍🏫 Teaching Experience

Assoc. Prof. Dr. Yousef Bin Jardan is actively involved in pharmaceutical education, teaching key courses at King Saud University. He instructs Pharmaceutical Calculations (PHT 210 – PharmD), equipping students with essential mathematical skills for accurate drug formulation and dosing. Additionally, he teaches Biopharmaceutics (PHT 414 – B.Pharm & PHT 417 – PharmD), focusing on drug absorption, distribution, metabolism, and elimination, crucial for understanding drug efficacy and safety. He also oversees Internship Training (PHTR 211 – PharmD), guiding students through practical experiences in clinical and pharmaceutical settings. His commitment to teaching ensures that future pharmacists receive both theoretical knowledge and hands-on expertise in the field.

🏢 Administrative Roles

Assoc. Prof. Dr. Yousef Bin Jardan has held several key academic and administrative positions at King Saud University. Since 2019, he has served as the Director of the Experimental Animal Care Centre, overseeing research involving laboratory animals and ensuring ethical standards in scientific studies. Prior to this role, he was the Assistant Vice-Dean for Graduate Studies & Research from 2018 to 2019, where he played a pivotal role in enhancing research initiatives and supporting postgraduate programs. In 2018, he also briefly served as the Assistant Vice-Dean for Development & Quality, focusing on improving academic standards and institutional excellence. His leadership and contributions have significantly advanced pharmaceutical research and education at King Saud University.

🏛️ Council & Committee Memberships

Pharmaceutics Department Council Member – (2017–Present)

Academic Committee Member – College of Pharmacy (2017–2018)

Annual Research Day Committee Member – (2017–2018)

🔬 Research Interests

Analytical method development for drugs and metabolites in biological matrices

Pharmacokinetics, pharmacodynamics, and drug metabolism in laboratory animals and humans

Drug-disease interactions using in vivo models

🏆 Awards & Recognitions

Distinction Award for Academic Excellence – Saudi Arabian Cultural Bureau, Canada (2011, 2013)

Graduate Student Award – University of Alberta (2014)

Graduate Students' Association Academic Travel Award – University of Alberta (2015, 2016)

CSPS Meeting Travel Award – Faculty of Pharmacy, University of Alberta (2015, 2016)

🎓 Licenses & Certifications

Licensed Pharmacist – Saudi Commission for Health Specialties (SCFHS) (2010–Present)

📜 Notable Publications

Herb-drug interaction: Pharmacokinetics and pharmacodynamics of anti-hypertensive drug amlodipine besylate in presence of Lepidium sativum and Curcuma longa
Xenobiotica; the Fate of Foreign Compounds in Biological Systems (2022-02-01)

Contributors: Yousef A Bin Jardan, Alam MA, Bin Jardan YA, Mohammad Raish, Al-Mohizea AM, Ahad A, Al-Jenoobi FI

Deciphering chemical profiling, pharmacological responses, and potential bioactive constituents of Saussurea lappa Decne. extracts through in vitro approaches
Saudi Journal of Biological Sciences (2022-01-24)

Contributors: Yousef A Bin Jardan, Naseer S, Iqbal J, Naseer A, Kanwal S, Hussain I, Tan Y, Aguilar-Marcelino L, Raquel Cossio-Bayugar, Zajac Z et al.

Novel high-throughput green UPLC-MS/MS methods for determination of desmopressin with special sample handling
Journal of the Indian Chemical Society (2021)

Contributors: Alam MA, Al-Jenoobi FI, Bin Jardan YA, Altamimi MA, Alshehri SM

Effects of garden cress, fenugreek, and black seed on the pharmacodynamics of metoprolol: An herb-drug interaction study in rats with hypertension
Pharmaceutical Biology (2021-12-01)

Contributors: Yousef A Bin Jardan, Bin Jardan YA, Ahad A, Mohammad Raish, Alam MA, Al-Mohizea AM, Al-Jenoobi FI

Eudragit-coated sporopollenin exine microcapsules (SEMC) of Phoenix dactylifera L. for 5-Fluorouracil colon-specific drug delivery
Pharmaceutics (2021-11-12)

Contributors: Yousef A Bin Jardan, Mohammad Raish, Dr. Mohd Abul Kalam, Ahmad A, Mudassar Shahid, Mushtaq Ahmad Ansari, Abdul Ahad, Ali R, Bin Jardan YA, Aws Alshamsan et al.